Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]
Titel:
Corrigendum to “Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration” [J. Autoimmun. 21 (2004) 283–293]
Auteur:
Nussenblatt, Robert B Thompson, Darby J.S Li, Zhuqing Chan, Chi C Peterson, Jan S Robinson, Randy R Shames, Richard S Nagarajan, Sudha Tang, Meina Tao Mailman, Michelle Velez, Gisela Roy, Chandra Levy-Clarke, Grace A Sujler, Eric B Djalilian, Ali Sen, Hatice Nida Al-Khatib, Shadi Ursea, Roxana Srivastava, Sunil Bamji, Allison Mellow, Susan Sran, Pushpa Waldmann, Thomas A Buggage, Ronald R